1.
Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study
by McGready, R, Dr
The Lancet infectious diseases, 2012, Vol.12 (5), p.388-396
2.
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial
by Gomes, MF, Dr
The Lancet (British edition), 2009, Vol.373 (9663), p.557-566
4.
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread
by Woodrow, Charles J
FEMS microbiology reviews, 2017-01-01, Vol.41 (1), p.34-48
5.
Counterfeit artesunate antimalarials in southeast Asia
by Newton, Paul N
The Lancet (British edition), 2003-07-12, Vol.362 (9378), p.169-169
6.
Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features
by Thwaites, GE
The Lancet (British edition), 2002-10-26, Vol.360 (9342), p.1287-1292
7.
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase...
by Phyo, Aung Pyae, MD
The Lancet infectious diseases, 2016, Vol.16 (1), p.61-69
8.
The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: an open cohort study
by Nguyen, Thuy-Nhien
The Lancet infectious diseases, 2018-05, Vol.18 (5), p.565-572
9.
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial
by Dondorp, Arjen M, MD
The Lancet (British edition), 2010, Vol.376 (9753), p.1647-1657
10.
Risk of sudden unexplained death after use of dihydroartemisinin–piperaquine for malaria: a systematic review and Bayesian meta-analysis
by Chan, Xin Hui S
The Lancet infectious diseases, 2018-08, Vol.18 (8), p.913-923
11.
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analy...
by Commons, Robert J
The Lancet infectious diseases, 2018-09, Vol.18 (9), p.1025-1034
12.
Counterfeit anti-infective drugs
by Newton, Paul N
The Lancet infectious diseases, 2006, Vol.6 (9), p.602-613
13.
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number
by Price, Ric N
The Lancet (British edition), 2004, Vol.364 (9432), p.438-447
14.
Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures
by Bicanic, T
AIDS (London), 2009, Vol.23 (6), p.701-706
15.
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
by Brouwer, Annemarie E
The Lancet (British edition), 2004-05-29, Vol.363 (9423), p.1764-1767
16.
Significant decadal-scale impact of volcanic eruptions on sea level and ocean heat content
by White, Neil J
Nature, 2005-11-03, Vol.438 (7064), p.74-77
17.
Malaria epidemic in Burundi
by Etchegorry, M Gastellu
The Lancet (British edition), 2001-03-31, Vol.357 (9261), p.1046-1047
18.
Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study
by Turner, P
Clinical microbiology and infection, 2013-12, Vol.19 (12), p.E551-E558
19.
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study
by Nosten, F
The Lancet (British edition), 2000-07-22, Vol.356 (9226), p.297-302
20.
Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development
by Guerin, Philippe J
The Lancet infectious diseases, 2002, Vol.2 (9), p.564-573
